PNV News: Immuron Chairman Transition - 30th Jun 2023, 8:00pm

annb0t

Top 20
Immuron Limited

MELBOURNE, Australia, June 30, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce the transition of Paul Brennan from Non-Executive Director to Chairman, effective July 1, 2023. Dr Roger Aston will continue on the Board, transitioning from Chairman to Non-Executive Director.

The Board determined that, having successfully steered the Company to US Food and Drug Administr...

>>> Read more: Immuron Chairman Transition
 
Top Bottom